摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-N-[(E)-(4-cyanophenyl)methylene]-2-methyl-2-propanesulfinamide | 475106-59-3

中文名称
——
中文别名
——
英文名称
(R)-N-[(E)-(4-cyanophenyl)methylene]-2-methyl-2-propanesulfinamide
英文别名
(NE,R)-N-[(4-cyanophenyl)methylidene]-2-methylpropane-2-sulfinamide
(R)-N-[(E)-(4-cyanophenyl)methylene]-2-methyl-2-propanesulfinamide化学式
CAS
475106-59-3
化学式
C12H14N2OS
mdl
——
分子量
234.322
InChiKey
OJTOIYQCINWNKT-SCZPIIQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    72.4
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (R)-N-[(E)-(4-cyanophenyl)methylene]-2-methyl-2-propanesulfinamide盐酸lithium hydroxide monohydrate三乙胺N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺正丁醇 为溶剂, 反应 44.0h, 生成 4-[(1S)-1-(4-{[(1R,5S,6S)-6-(5,5-dimethyl-4,5-dihydro-1,2-oxazol-3-yl)-3-azabicyclo[3.1.0]hex-3-yl]carbonyl}-1H-imidazol-1-yl)ethyl]benzonitrile
    参考文献:
    名称:
    [EN] 3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF
    [FR] DÉRIVÉS DE 3-AZABICYCLO(3.1.0)HEXANE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE KDM5 ET LEUR UTILISATION
    摘要:
    本发明提供了KDM5抑制剂。本文所披露的化合物由一般式(I)表示:其中所有符号的含义与规范中描述的定义相同;或其盐可用作癌症、亨廷顿病、阿尔茨海默病等的预防和/或治疗剂。
    公开号:
    WO2021223699A1
  • 作为产物:
    描述:
    4-氰基苯甲醛(R)-(+)-叔丁基亚磺酰胺titanium(IV) tetraethanolate 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 以93.345%的产率得到(R)-N-[(E)-(4-cyanophenyl)methylene]-2-methyl-2-propanesulfinamide
    参考文献:
    名称:
    [EN] 3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF
    [FR] DÉRIVÉS DE 3-AZABICYCLO(3.1.0)HEXANE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE KDM5 ET LEUR UTILISATION
    摘要:
    本发明提供了KDM5抑制剂。本文所披露的化合物由一般式(I)表示:其中所有符号的含义与规范中描述的定义相同;或其盐可用作癌症、亨廷顿病、阿尔茨海默病等的预防和/或治疗剂。
    公开号:
    WO2021223699A1
点击查看最新优质反应信息

文献信息

  • 3-Component palladium–indium mediated diastereoselective cascade allylation of imines with allenes and aryl iodidesElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b202940e/
    作者:Ian R. Cooper、Ronald Grigg、William S. MacLachlan、Mark Thornton-Pett、Visuvanathar Sridharan
    DOI:10.1039/b202940e
    日期:2002.6.19
    A new palladium–indium diastereoselective cascade allylation of imines using allenes and aryl iodides is described; N-tosyl and N-aryl homoallyl amines were obtained in moderate to good yields and excellent diastereoselectivity was observed when enantiomerically pure N-tert-butanesulfinyl imines were employed in the cascade.
    该研究描述了一种利用烯和芳基化物对亚胺进行非对映选择性级联烯丙基化的新方法;在级联反应中使用对映体纯的 N-叔丁烷亚磺酰亚胺时,可获得 N-对甲基苯磺酰亚胺和 N-芳基均烯丙基胺,产率为中等到良好,并观察到极好的非对映选择性。
  • Amide compounds and use thereof
    申请人:ALPHALA CO., LTD.
    公开号:US10882837B2
    公开(公告)日:2021-01-05
    Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    公开了下式(I)化合物及其药学上可接受的盐,其中变量R1、R2、L和Z中的每一个在本文中定义。还公开了用式(I)化合物或其盐和含有该化合物的药物组合物降低血糖平和治疗胰高血糖素相关疾病的方法。
  • Stereocontrolled Synthesis of Methyl Silanediol Peptide Mimics
    作者:Lone Nielsen、Karl B. Lindsay、Jesper Faber、Niels Christian Nielsen、Troels Skrydstrup
    DOI:10.1021/jo701907d
    日期:2007.12.1
    The treatment of chiral sulfinimines with (methyldiphenylsilyl)lithium gives alpha-(methyldiphenylsilyl)sulfinamides with excellent diastereoselectivity, and in good yield. The presence of alpha-protons on the imines is also well tolerated. The sulfinamide auxiliary is easily removed via treatment with methanolic HCl and the resulting amine extended into peptide chains accordingly. The diphenylsilyl moiety is a resilient protecting group for the corresponding silanediol, which can be unmasked via treatment with TfOH, followed by aqueous hydrolysis. The crude silanediol may be isolated and purified as its corresponding bis-TMS siloxane via protection with TMSCI, and converted back to the desired silanediol via hydrolysis with aqueous KOH. Efforts to apply this approach to biologically relevant silanediol peptide mimics, with a view to protease inhibition, are described.
  • Efficient Trapping of Oxonium Ylides with Imines: A Highly Diastereoselective Three-Component Reaction for the Synthesis of β-Amino-α-hydroxyesters with Quaternary Stereocenters
    作者:Haoxi Huang、Xin Guo、Wenhao Hu
    DOI:10.1002/anie.200604389
    日期:2007.2.12
  • Novel Peptoid Building Blocks: Synthesis of Functionalized Aromatic Helix-Inducing Submonomers
    作者:Jiwon Seo、Annelise E. Barron、Ronald N. Zuckermann
    DOI:10.1021/ol902660p
    日期:2010.2.5
    Peptoids, oligo-N-substituted glycines, can fold into well-defined helical secondary structures. The design and synthesis of new peptoid building blocks that are capable of both (a) inducing a helical secondary structure and (b) decorating the helices with chemical functionalities are reported. Peptoid heptamers containing carboxamide, carboxylic acid or thiol functionalities were synthesized, and the resulting peptoids were shown to form stable helices. A thiol-containing peptoid readily formed the homodisulfide. providing a convenient route to prepare peptoid helix homodimers.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫